We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shire | LSE:SHP | London | Ordinary Share | JE00B2QKY057 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4,690.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSHP Holding(s) in Company January 7, 2019 -- Shire plc (LSE: SHP, NASDAQ: SHPG) 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached(ii) Shire Plc : JE00B2QKY057 ------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------- 1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Non-UK issuer X ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------ 2. Reason for the notification (please mark the appropriate box or boxes with an "X") ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------ An acquisition or disposal of financial instruments X ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------ An event changing the breakdown of voting rights ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------ Other (please specify)(iii) : ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------ 3. Details of person subject to the notification obligation(iv) UBS Investment Bank Name UBS Group AG Zürich City and country of registered office (if applicable) Switzerland 4. Full name of shareholder(s) (if different from 3.)(v) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Name UBS AG London Branch ------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------- City and country of registered office (if applicable) London, United Kingdom ------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------- 5. Date on which the threshold was crossed or reached(vi) : 3 January 2019 ------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------- 6. Date on which issuer notified (DD/MM/YYYY): 7 January 2019 ------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------- 7. Total positions of person(s) subject to the notification obligation ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- % of voting rights attached to shares (total of 8. % of voting rights through financial instruments Total number of voting rights A) (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) of issuer(vii) ----------------------------------------------------- ----------------------------------------------------------------------------------------- -------------------------------------------------- ----------------------------------------------- ------------------------------ Resulting situation on the date on which threshold was crossed or reached 6.80% 0.78% 7.58% 918,120,398 ----------------------------------------------------- ------------------------------------------ -------------------------------------------- ------------------ ----------------------------- ---------------------------- ---------------- ------------ ---------------- Position of previous notification (if applicable) 6.86% 2.23% 9.10% ----------------------------------------------------- ------------------------------------------ -------------------------------------------- ------------------ ----------------------------- ---------------------------- ---------------- ------------------------------ 8. Notified details of the resulting situation on the date on which the threshold was crossed or reached(viii) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Number of voting rights(ix) % of voting rights --------------------------------------------------- Class/type of shares Direct Indirect Direct Indirect
ISIN code (if possible) (Art 9 of Directive 2004/109/EC) (DTR5.1) (Art 10 of Directive 2004/109/EC) (DTR5.2.1) (Art 9 of Directive 2004/109/EC) (DTR5.1) (Art 10 of Directive 2004/109/EC) (DTR5.2.1) ---------------------------------------------------- ------------------------------------------- --------------------------------------------- -------------------------------------------------------------------------------- ------------------------------------------------- JE00B2QKY057 62'432'281 6.80% ---------------------------------------------------- ------------------------------------------- --------------------------------------------- -------------------------------------------------------------------------------- ------------------------------- --------------- SUBTOTAL 8. A 62'432'281 6.80% ---------------------------------------------------- ------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------- --------------- B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a)) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Number of voting rights that may be acquired if the Expiration Exercise/ instrument is Type of financial instrument date(x) Conversion Period(xi) exercised/converted. % of voting rights ---------------------------------------------------- ------------------------------------------- --------------------------------------------- -------------------------------------------------------------------------------- ------------------------------------------------- Right to recall lent ADRs (US82481R1068) Anytime 396'000 0.04% ---------------------------------------------------- ------------------------------------------- --------------------------------------------- -------------------------------------------------------------------------------- ------------------------------- --------------- US82481R1068 5'174'370 0.56% ---------------------------------------------------- ------------------------------------------- --------------------------------------------- -------------------------------------------------------------------------------- ------------------------------- --------------- Physically settled Long Call Options 18/01/2019 to 18/04/2019 933'000 0.10% ---------------------------------------------------- ------------------------------------------- --------------------------------------------- -------------------------------------------------------------------------------- ------------------------------- --------------- SUBTOTAL 8. B 1 6'503'370 0.71% --------------------------------------------- -------------------------------------------------------------------------------- ------------------------------- --------------- B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Expiration Exercise/ Physical or cash Type of financial instrument date(x) Conversion Period (xi) settlement(xii) Number of voting rights % of voting rights --------------------------------------------------- -------------------------------------------- --------------------------------------------- -------------------------------------------------- ---------------------------- ------------------------------------------------- Short Put Options 18/01/2019 Physical 658'800 0.07% --------------------------------------------------- -------------------------------------------- --------------------------------------------- -------------------------------------------------- ---------------------------- ------------------------------- --------------- SUBTOTAL 8.B.2 658'800 0.07% -------------------------------------------------- ---------------------------- ------------------------------- --------------- 9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X") Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer(xiii) Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity(xiv) (please add additional rows as necessary) X ------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------- % of voting rights if it equals or is higher than % of voting rights through financial instruments if Total of both if it equals or is higher than the notifiable Name(xv) the notifiable threshold it equals or is higher than the notifiable threshold threshold ------------ --------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------------- UBS Group AG ------------ --------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------------- UBS AG ------------ --------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------------- UBS AG London Branch 6.80% 7.58% ------------ ------------------ ------------------------------ ----------------------------------------------------- ---------------------- ------------------------------------ UBS Group AG ------------ --------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------------- UBS AG ------------ --------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------------- UBS Limited
------------ --------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------------- UBS Group AG ------------ --------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------------- UBS AG ------------ --------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------------- UBS Switzerland AG ------------ --------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------------- UBS Group AG ------------ --------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------------- UBS AG ------------ --------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------------- UBS Americas Holding LLC ------------ --------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------------- UBS Americas Inc. ------------ --------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------------- UBS Securities LLC ------------ --------------------------------------------------- ----------------------------------------------------- ------------------------------------------------------------- 10. In case of proxy voting, please identify: ----------------------------------------------------- Name of the proxy holder --------------------------------------------------- The number and % of voting rights held --------------------------------------------------- The date until which the voting rights will be held --------------------------------------------------- 11. Additional information(xvi) ----------------------------------------------------- Place of completion Opfikon, Switzerland ------------------- -------------------- Date of completion 07.01.2019 ------------------- -------------------- For further information please contact: Investor Relations Christoph Brackmann christoph.brackmann@shire.com +41 41 288 41 29 Sun Kim sun.kim@shire.com +1 617 588 8175 Scott Burrows scott.burrows@shire.com +41 41 288 4195 Media Katie Joyce kjoyce@shire.com +1 781 482 2779 NOTES TO EDITORS About Shire Shire is the global biotechnology leader serving patients with rare diseases and specialized conditions. We seek to push boundaries through discovering and delivering new possibilities for patient communities who often have few or no other champions. Relentlessly on the edge of what's next, we are serial innovators with a diverse pipeline offering fresh thinking and new hope. Serving patients and partnering with healthcare communities in over 100 countries, we strive to be part of the entire patient journey to enable earlier diagnosis, raise standards of care, accelerate access to treatment, and support patients. Our diverse portfolio of therapeutic areas includes Immunology, Hematology, Genetic Diseases, Neuroscience, Internal Medicine, and Ophthalmics. Championing patients is our call to action - it brings the opportunity - and responsibility - to change people's lives. https://www.globenewswire.com/Tracker?data=vAa6XY7wcDQA3UjgcCXVq7VqKN9GX3z1jLwa-g7czTGD_rE4Jx0Us_R6xXmX4WdOlAhJpM-Lj-qZKjMhezgEQA== www.shire.com
(END) Dow Jones Newswires
January 07, 2019 12:00 ET (17:00 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Shire Chart |
1 Month Shire Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions